Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Uracil Tegafur Capsules
Indication: Used for digestive tract tumors, such as gastric cancer, colon cancer, rectal cancer, liver cancer, pancreatic cancer, etc., as well as head and neck cancer, lung cancer, and breast cancer.
Fluorouracil implant
Indication: Mainly used for esophageal cancer, colorectal cancer, gastric cancer, etc.
Calcium Folinate Capsules
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethoprim or trimethoprim). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment with methotrexate. 3. Also used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil for advanced colon and rectal cancer.
Manufacturer:
Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd.
Addi Injection
Manufacturer:
Guizhou Yibai Pharmaceutical Co., Ltd.
Oxaliplatin
Indication: Combined with 5-fluorouracil and folinic acid (leucovorin): first-line treatment of metastatic colorectal cancer; adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumor. This indication is based on the results of foreign clinical studies.
Manufacturer:
Lianyungang JARI Pharmaceutical Co., Ltd.
Oxaliplatin
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Wuxi Taxus Pharmaceutical Co., Ltd.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Related Ingredients
-
5-Fluorouracil list
51-21-8 -
Calcium folinatc list
6035-45-6 -
1,10-Phenanthroline hydrate list
5144-89-8 -
Oxaliplatin list
61825-94-3